Neural Mechanisms of Psychedelics: Panel Session - Ben Sessa, Robin Carhart-Harris, David Nichols, A

Neural mechanisms of psychedelics and psychopharmacological research are evaluated during this expert panel discussion. The conversation emphasizes how serotonin receptor activation is only one component of the therapeutic effects of these substances, and identifies dopamine and norepinephrine systems as equally important factors for psychoactive outcomes. The discussion further addresses the practical obstacles to clinical implementation, including ethical concerns and regulatory hurdles for research. Panelists advocate for a more nuanced public framing of psychedelic use, emphasizing safety, clinical validation, and the destigmatization of these substances to support their development into legitimate medical treatments.